Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 14-(ethylamino)-8,9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione
2. E 6201
3. E-6201
4. E6201 Cpd
1. E6201
2. E-6201
3. Unii-czp9gb25ho
4. Czp9gb25ho
5. Er-806201
6. E 6201
7. 603987-35-5
8. (3s,4r,5z,8s,9s,11e)-14-(ethylamino)-8,9,16-trihydroxy-3,4-dimethyl-3,4,9,10-tetrahydro-1h-benzo[c][1]oxacyclotetradecine-1,7(8h)-dione
9. (4~{s},5~{r},6~{z},9~{s},10~{s},12~{e})-16-(ethylamino)-4,5-dimethyl-9,10,18-tris(oxidanyl)-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione
10. Gtpl7836
11. Schembl6983345
12. Chembl1097999
13. Bdbm50515043
14. Zinc34374629
15. Db11687
16. (3s,4r,5z,8s,9s,11e)-14-(ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione
17. Hy-15496
18. Cs-0006796
19. J-504641
20. Q27077143
21. (4s,5r,6z,9s,10s,12e)-16-(ethylamino)-9,10,18-trihydroxy-4,5-dimethyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione
22. (4s,5r,6z,9s,10s,12e)-16-ethylamino-9,10,18-trihydroxy-4,5-dimethyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione
23. 1108193-99-2
24. 1h-2-benzoxacyclotetradecin-1,7(8h)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3s,4r,5z,8s,9s,11e)-
25. 1h-2-benzoxacyclotetradecin-1,7(8h)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3s,4r,5z,8s,9s,11e) -
| Molecular Weight | 389.4 g/mol |
|---|---|
| Molecular Formula | C21H27NO6 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 389.18383758 g/mol |
| Monoisotopic Mass | 389.18383758 g/mol |
| Topological Polar Surface Area | 116 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 604 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
81
PharmaCompass offers a list of E6201 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right E6201 manufacturer or E6201 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred E6201 manufacturer or E6201 supplier.
PharmaCompass also assists you with knowing the E6201 API Price utilized in the formulation of products. E6201 API Price is not always fixed or binding as the E6201 Price is obtained through a variety of data sources. The E6201 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A E6201 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E6201, including repackagers and relabelers. The FDA regulates E6201 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E6201 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A E6201 supplier is an individual or a company that provides E6201 active pharmaceutical ingredient (API) or E6201 finished formulations upon request. The E6201 suppliers may include E6201 API manufacturers, exporters, distributors and traders.
E6201 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of E6201 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right E6201 GMP manufacturer or E6201 GMP API supplier for your needs.
A E6201 CoA (Certificate of Analysis) is a formal document that attests to E6201's compliance with E6201 specifications and serves as a tool for batch-level quality control.
E6201 CoA mostly includes findings from lab analyses of a specific batch. For each E6201 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
E6201 may be tested according to a variety of international standards, such as European Pharmacopoeia (E6201 EP), E6201 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (E6201 USP).
